PainReform (PRFX) Short Interest Ratio & Short Volume $2.23 +0.07 (+3.24%) As of 01:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PainReform Short Interest DataPainReform (PRFX) has a short interest of 62,200 shares, representing 3.77% of the float (the number of shares available for trading by the public). This marks a -1.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.09 million shares to cover all short positions.Current Short Interest62,200 sharesPrevious Short Interest63,000 sharesChange Vs. Previous Month-1.27%Dollar Volume Sold Short$173,538.00Short Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares875,000 sharesFloat Size1,650,000 sharesShort Percent of Float3.77%Today's Trading Volume11,608 sharesAverage Trading Volume1,094,713 sharesToday's Volume Vs. Average1% Short Selling PainReform? Sign up to receive the latest short interest report for PainReform and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRFX Short Interest Over TimePRFX Days to Cover Over TimePRFX Percentage of Float Shorted Over Time Remove Ads PainReform Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202562,200 shares $173,538.00 -1.3%3.8%0 $2.79 2/28/202563,000 shares $198,450.00 +85.3%7.4%0 $3.15 2/15/202534,000 shares $95,880.00 -47.5%4.0%0 $2.82 1/31/202564,800 shares $202,176.00 +153.1%7.7%0 $3.12 1/15/202525,600 shares $73,472.00 -54.2%3.0%0 $2.87 12/31/202455,900 shares $187,824.00 +17.7%6.7%0 $3.36 12/15/202447,500 shares $147,725.00 -9.2%8.5%0 $3.11 11/30/202452,300 shares $145,394.00 +79.7%9.3%0 $2.78 11/15/202429,100 shares $61,785.12 -76.0%5.2%0 $2.12 10/31/2024121,100 shares $60,550.00 +98.2%6.2%0.2 $0.50 Get the Latest News and Ratings for PRFX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PainReform and its competitors with MarketBeat's FREE daily newsletter. 10/15/202461,100 shares $34,827.00 +6.1%3.1%0.1 $0.57 9/30/202457,600 shares $35,619.84 -11.4%15.4%0.1 $0.62 9/15/202465,000 shares $56,550.00 +2,221.4%17.4%0.2 $0.87 8/31/20242,800 shares $624.40 -96.4%N/A0 $0.22 8/15/202477,000 shares $23,977.80 -14.7%2.6%0.1 $0.31 7/31/202490,300 shares $36,526.35 +75.3%3.3%0.4 $0.40 7/15/202451,500 shares $28,067.50 -1.3%1.9%0.3 $0.55 6/30/202452,200 shares $25,056.00 -56.2%2.7%0.2 $0.48 6/15/2024119,100 shares $61,932.00 +653.8%6.2%0.5 $0.52 5/31/202415,800 shares $11,218.00 -47.2%0.8%0.1 $0.71 5/15/202429,900 shares $23,922.99 +51.0%1.6%0.2 $0.80 4/30/202419,800 shares $18,286.13 -63.7%1.2%0.1 $0.92 4/15/202454,600 shares $53,557.14 +232.9%3.0%0.4 $0.98 3/31/202416,400 shares $29,848.00 +18.0%1.2%0.1 $1.82 3/15/202413,900 shares $25,437.00 +504.4%1.0%0.6 $1.83 2/29/20242,300 shares $4,370.00 -52.1%0.1%0.1 $1.90 2/15/20244,800 shares $10,224.00 +23.1%0.3%0.2 $2.13 1/31/20243,900 shares $7,800.39 -53.6%0.3%0.1 $2.00 1/15/20248,400 shares $20,580.00 No Change0.7%0.3 $2.45 12/31/20238,400 shares $23,100.00 +21.7%0.7%0.3 $2.75 12/15/20236,900 shares $18,078.00 +15.0%0.6%0.4 $2.62 11/30/20236,000 shares $15,000.00 +1,400.0%0.5%0.3 $2.50 11/15/2023400 shares $852.00 -84.0%0.0%0 $2.13 10/31/20232,500 shares $5,450.00 +257.1%0.2%0.1 $2.18 10/15/2023700 shares $1,764.00 +40.0%0.1%0 $2.52 9/30/2023500 shares $1,740.00 -89.8%0.1%0 $3.48 9/15/20234,900 shares $19,061.00 +11.4%0.5%0 $3.89 8/31/20234,400 shares $20,988.00 -59.3%0.4%0 $4.77 8/15/202310,800 shares $62,964.00 -90.2%1.0%0 $5.83 7/31/2023110,400 shares $776,112.00 +106.7%10.4%0.1 $7.03Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.There's no time to waste. As far as I can tell, the best way to profit from this project is to make 7/15/202353,400 shares $432,540.00 +820.7%6.3%0 $8.10 6/30/20235,800 shares $31,836.20 -90.9%N/A0 $5.49 6/15/202364,000 shares $31,993.60 -10.4%N/A1.3 $0.50 5/31/202371,400 shares $33,101.04 -8.5%1.2%1.4 $0.46 5/15/202378,000 shares $47,010.60 +16.2%1.3%1.6 $0.60 4/30/202367,100 shares $37,924.92 +3.9%1.1%0.2 $0.57 4/15/202364,600 shares $39,005.48 -4.2%1.1%0.2 $0.60 3/31/202367,400 shares $46,506.00 +28.4%1.2%0.2 $0.69 3/15/202352,500 shares $26,507.25 -53.0%1.0%0.2 $0.50 2/28/2023111,800 shares $69,863.82 -49.7%2.1%0.4 $0.62 2/15/2023222,200 shares $131,764.60 +3,074.3%4.2%0.8 $0.59 1/31/20237,000 shares $3,500.00 +11.1%0.1%0 $0.50 1/15/20236,300 shares $3,150.00 -59.4%0.1%0.4 $0.50 12/30/202215,500 shares $6,396.85 -29.2%0.3%1 $0.41 12/15/202221,900 shares $9,756.45 +2,637.5%0.4%1.4 $0.45 11/30/2022800 shares $356.04 +100.0%0.0%0.1 $0.45 11/15/2022400 shares $220.04 -87.9%0.0%0 $0.55 10/31/20223,300 shares $1,980.00 -66.0%0.1%0.4 $0.60 10/15/20229,700 shares $6,330.22 +79.6%0.2%0.7 $0.65 9/30/20225,400 shares $3,726.00 -32.5%0.1%0.3 $0.69 9/15/20228,000 shares $5,841.21 -13.0%0.1%0.4 $0.73 8/31/20229,200 shares $6,116.16 -56.8%0.2%0.4 $0.66 8/15/202221,300 shares $17,572.50 +49.0%0.4%0.8 $0.83 7/31/202214,300 shares $10,153.00 +98.6%0.3%0.5 $0.71 7/15/20227,200 shares $5,760.00 +1,100.0%0.1%0.3 $0.80 6/30/2022600 shares $568.80 -88.9%0.0%0 $0.95 6/15/20225,400 shares $5,562.00 -14.3%0.1%0.2 $1.03 5/31/20226,300 shares $5,668.73 -77.7%0.1%0.1 $0.90 5/15/202228,200 shares $22,080.60 +104.4%0.5%0.3 $0.78 4/30/202213,800 shares $12,958.20 -53.4%0.3%0.2 $0.94 4/15/202229,600 shares $35,520.00 -38.3%0.6%0.3 $1.20 3/31/202248,000 shares $59,520.00 -36.6%0.9%0.4 $1.24 3/15/202275,700 shares $84,027.00 -13.9%1.5%0.5 $1.11 2/28/202287,900 shares $88,779.00 +4.8%1.7%0.7 $1.01 2/15/202283,900 shares $95,646.00 -35.9%1.6%0.5 $1.14 1/31/2022130,800 shares $143,893.08 +35.0%2.5%0.3 $1.10 1/15/202296,900 shares $134,691.00 +78.5%2.0%0.2 $1.39 12/31/202154,300 shares $72,219.00 -50.4%1.1%0.1 $1.33 12/15/2021109,400 shares $170,664.00 -62.7%2.3%0.2 $1.56 11/30/2021293,000 shares $524,470.00 +293.8%6.0%0.6 $1.79 11/15/202174,400 shares $188,976.00 +98.4%1.5%0.1 $2.54 10/29/202137,500 shares $88,125.00 -31.7%0.8%0.1 $2.35 10/15/202154,900 shares $145,485.00 +193.6%1.2%0.1 $2.65 9/30/202118,700 shares $51,799.00 -92.1%0.4%0 $2.77 9/15/2021236,800 shares $680,800.00 -43.4%5.3%0.1 $2.88 8/31/2021418,300 shares $1.23 million -14.9%9.4%0.3 $2.95 8/13/2021491,700 shares $1.33 million +24.3%11.1%0.3 $2.71 7/30/2021395,600 shares $1.14 million +306.6%8.9%0.3 $2.88 7/15/202197,300 shares $295,558.48 +40.0%2.2%0.1 $3.04 6/30/202169,500 shares $195,990.00 +2.7%1.6%0.3 $2.82Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.There's no time to waste. As far as I can tell, the best way to profit from this project is to make 6/15/202167,700 shares $190,237.00 -1.7%1.5%0.3 $2.81 5/28/202168,900 shares $206,700.00 -13.2%1.6%0.3 $3.00 5/14/202179,400 shares $195,324.00 -20.2%1.8%0.4 $2.46 4/30/202199,500 shares $340,290.00 -12.4%2.2%0.4 $3.42 4/15/2021113,600 shares $415,776.00 +59.3%2.6%0.5 $3.66 3/31/202171,300 shares $309,442.00 +90.6%2.0%0.4 $4.34 3/15/202137,400 shares $200,464.00 -66.4%1.2%0.2 $5.36 2/26/2021111,400 shares $701,820.00 +300.7%3.6%0.4 $6.30 2/12/202127,800 shares $150,398.00 +219.5%0.9%0.1 $5.41 1/29/20218,700 shares $37,932.00 +155.9%0.3%0 $4.36 1/15/20213,400 shares $14,960.00 No Change0.1%0 $4.40 PRFX Short Interest - Frequently Asked Questions What is PainReform's current short interest? Short interest is the volume of PainReform shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 62,200 shares of PRFX short. 3.77% of PainReform's shares are currently sold short. Learn More on PainReform's current short interest. What is a good short interest percentage for PainReform? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.77% of PainReform's floating shares are currently sold short. Is PainReform's short interest increasing or decreasing? PainReform saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 62,200 shares, a decline of 1.3% from the previous total of 63,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PainReform's float size? PainReform currently has issued a total of 875,000 shares. Some of PainReform's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PainReform currently has a public float of 1,650,000 shares. How does PainReform's short interest compare to its competitors? 3.77% of PainReform's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PainReform: Phio Pharmaceuticals Corp. (1.63%), Galecto, Inc. (2.43%), Ainos, Inc. (11.98%), Addex Therapeutics Ltd (0.13%), Brainstorm Cell Therapeutics Inc. (2.77%), Onconetix, Inc. (7.86%), Cyclerion Therapeutics, Inc. (3.87%), Aytu BioPharma, Inc. (1.91%), BioXcel Therapeutics, Inc. (8.08%), Hoth Therapeutics, Inc. (2.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short PainReform stock? Short selling PRFX is an investing strategy that aims to generate trading profit from PainReform as its price is falling. PRFX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PainReform? A short squeeze for PainReform occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRFX, which in turn drives the price of the stock up even further. How often is PainReform's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRFX, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies PHIO Short Interest GLTO Short Interest AIMD Short Interest ADXN Short Interest BCLI Short Interest ONCO Short Interest CYCN Short Interest AYTU Short Interest BTAI Short Interest HOTH Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRFX) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainReform Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PainReform With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
